General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Clover Health regains Nasdaq compliance with stock bid price By Investing.com | news.google.com • |
Clover Health regains compliance with Nasdaq minimum bid price requirement | news.google.com • |
Clover Health regains Nasdaq compliance with stock bid price By Investing.com | news.google.com • |
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement | globenewswire.com • |
Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement | news.google.com • |
Clover Health Investments (NASDAQ:CLOV) Trading 5.6% Higher | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-13 | 2024-06 | -0.04 | N/A | N/A | N/A |
2024-05-07 | 2024-03 | -0.07 | -0.05 | 0.02 | 28.57% |
2024-03-12 | 2023-12 | -0.18 | -0.12 | 0.06 | 33.33% |
2024-03-12 | 2023-12 | -0.18 | N/A | N/A | N/A |
2023-11-06 | 2023-09 | -0.1 | -0.09 | 0.01 | 10.00% |
2023-11-06 | 2023-09 | -0.1 | N/A | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-10 | Citigroup | Upgrade | Neutral | Neutral |
2023-03-05 | Canaccord Genuity | Upgrade | Buy | |
2023-03-05 | Credit Suisse | Upgrade | Underperform | |
2022-11-15 | Citigroup | Upgrade | Neutral | |
2022-11-07 | SVB Leerink | Upgrade | Market Perform | |
2022-08-08 | Citigroup | Upgrade | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-01-02 | CLINTON CHELSEA | Director | 541.84K | Stock Award(Grant) |
2024-01-02 | EDWARDS CARLADENISE ARMBRISTER | Director | 412.25K | Stock Award(Grant) |
2024-06-16 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 877.57K | Purchase |
2024-01-02 | KOUZOUKAS DEMETRIOS L | Director | 465.64K | Stock Award(Grant) |
2023-10-30 | LEFFLER SCOTT J. | Chief Technology Officer | 3.09M | Stock Award(Grant) |
2024-05-16 | LOENGARD ANNA U | Director | 0.00 | Purchase |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 31.43M | 28.20M | 7.92% |
2023-06-29 | Renaissance Technologies, LLC | 8.85M | 7.94M | 2.23% |
2023-06-29 | Blackrock Inc. | 7.77M | 6.97M | 1.96% |
2023-06-29 | Citadel Advisors Llc | 5.35M | 4.80M | 1.35% |
2023-06-29 | PNC Financial Services Group, Inc. | 5.26M | 4.72M | 1.33% |
2023-06-29 | Millennium Management Llc | 4.65M | 4.17M | 1.17% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 10.28M | 9.22M | 2.59% |
2023-06-29 | Vanguard Small-Cap Index Fund | 9.15M | 8.21M | 2.30% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 5.24M | 4.70M | 1.32% |
2023-06-29 | Vanguard Extended Market Index Fund | 4.77M | 4.28M | 1.20% |
2023-05-30 | Fidelity Extended Market Index Fund | 1.70M | 1.44M | 0.43% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 1.37M | 1.16M | 0.34% |
Must be at $2
Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10 Ipo price at $10
I will dont sell befor IPO price at $10
$10 ipo price
Today ipo price at $10 tomrow 100
Squeezing to $100
Good sounds
Sound goood ️️️
🟢A $CLOV
Clover Health
President of the company Vivek Garipalli
Buy 877,567 for $1.14/share
With a total value of $1,000,426.38
🟢A $CLOV
Clover Health
President of the company Vivek Garipalli
Buy 877,567 for $1.14/share
With a total value of $1,000,426.38
Nice ER
All stocks going up why $CLOV no
Clove wana go like $HOLO
$HOLO from 1 to 48 going up 2000%
Who next $clov !!!!
Go up fkrs
Go clove matha faka
1 cent fkrs
The last months of losses Biden will leave BE STRONG ️️️️️️️️️️
$CLOV soup again.
$CLOV volumen is huge. But 1.10 is the Everest..